| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | Vandetanib | FIMM | pan-cancer | AAC | -0.0079 | 1 |
| mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | Bicalutamide | GDSC1000 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | temsirolimus | FIMM | pan-cancer | AAC | -0.0052 | 1 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | -0.0009 | 1 |